RecruitingNCT05585229
Psilocybin-assisted therapy and opioid tapering for chronic pain
About this title
Read the official source — NCT05585229Medication studyAges 19–75CanadaAddiction
Understand this study
Who could participate?
Listed age limits: 19 years to 75 years.
- Listed locations
- KelownaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 27, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 10
- Sponsor
- University of British Columbia
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 19 Years to 75 Years
- Official registry ID
- NCT05585229
- Official title
Show the full official title
Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility Study
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Kelowna
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of British Columbia, a university.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin-assisted Psychotherapy.
Who can participate?
Listed age limits: 19 years to 75 years.
Is this study still recruiting?
The registry lists this study as recruiting.
